The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Shreyasee Das, Marie-Paule E. van Engelen, Julie Goossens, Dirk Jacobs, Bram Bongers, Jay L. P. Fieldhouse, Yolande A. L. Pijnenburg, Charlotte E. Teunissen, Eugeen Vanmechelen & Inge M. W. Verberk.
Alz Res Therapy 2024 Feb.
Next PostPlasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET